Cohen Raymond W's Form 4 filing
Axonics, Inc. (AXNX) · filed Mar 16, 2022
- Accession no.
- 0001562180-22-002687
- Filed
- Mar 16, 2022
- Trade date
- Mar 14, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 5 non-derivative transactions and 0 derivative transactions. Open-market sales total $2.64M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Cohen Raymond WCIK 0001258288 | Director, Officer (Chief Executive Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 14, 2022 | Common Stock | SSaleDisposed | −17,787 | $50.42 | −$896,820.54 | 275,848 | Direct | |
| Mar 14, 2022 | Common Stock | SSaleDisposed | −2,100 | $51.40 | −$107,940 | 273,748 | Direct | |
| Mar 14, 2022 | Common Stock | SSaleDisposed | −1,981 | $52.66 | −$104,319.46 | 271,767 | Direct | |
| Mar 14, 2022 | Common Stock | SSaleDisposed | −11,232 | $53.95 | −$605,966.4 | 260,535 | Direct | |
| Mar 14, 2022 | Common Stock | SSaleDisposed | −16,900 | $54.80 | −$926,120 | 243,635 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.